問卷

TPIDB > Principal Investigator

Principal Investigator


Linkou Chang Gung Medical Foundation (在職)

Division of Neurology

更新時間:2023-09-19

呂榮國
  • Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

2Cases

2020-07-15 - 2026-07-31

Phase IV

Active
A 12-month, Prospective, Multi-center Post-authorization Commitment (PAC) Study Monitoring Safety in Adult Patients With Relapsing-remitting Multiple Sclerosis Newly Initiated on Gilenya (Fingolimod) in Taiwan (SPRING)
  • Condition/Disease

    Multiple Sclerosis

  • Test Drug

    Gilenya hard Capsules 0.5mg

Participate Sites
6Sites

Not yet recruiting3Sites

Recruiting3Sites

2019-08-19 - 2024-04-30

Phase III

Completed
A 12-week phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of once monthly subcutaneous erenumab 70 mg in adult chronic migraine patients
  • Condition/Disease

    Chronic Migraine

  • Test Drug

    AMG334 (erenumab)

Participate Sites
9Sites

Recruiting2Sites

Terminated7Sites